Join us for the
23rd Annual Scientific Meeting of the ISCP
Kyoto, Japan: May 26th-27th 2018
Promoting and facilitating strategies to improve cardiovascular health worldwide
ISCP Featured Sessions 2017
ISCP Webinar: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
e-Learning & Training
Specific training and best practice modules for cardiovascular physicians and surgeons, and medical practitioners.
-
Expert Reviews
Independent summary information selected and analysed by our expert Editorial Board.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists,scientists and medical practitioners.
Upcoming Events
26
May
5
Jun
Cardiología 2018 – La Habana, Cuba
Endorsed Meeting 05 Jun 2018
31
May
28
Sep
22
Oct
28
Oct
IDSS 2018 – Tel Aviv, Israel
Conferences 28 Oct 2018
Highlights
The latest reviews, resources and expert analysis from our website.
Expert Opinions: The Complex Management of End-Stage Heart Failure: The Importance of Quality of Life
Posted on March 28, 2018
Expert Reviews: Cardiovascular Management of Adults with Marfan Syndrome
Posted on May 09, 2018
Clinical Trials: Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes
Posted on May 22, 2018
Webinars and e-Learning: Cardiovascular Risk Management of Diabetes and SGLT2 Inhibitors
Posted on July 12, 2017
newsfeed
WHO launches plan to eliminate industrially-produced trans-fatty acids from global food supply
Posted on May 17, 2018
The World Heart Federation welcomes to the launch of the World Health Organization’s REPLACE Action Package, a step-by-step guide for the elimination of industrially-produced... more
Elevating Hypertension on the Public Health Agenda
Posted on May 17, 2018
Marking World Hypertension Day on May 17, the World Heart Federation is taking stock of its recent initiatives to accelerate progress in the management and prevention... more
SIAComunidad’s ‘For the American Heart’ initiatives peak for World Hypertension Day
Posted on May 16, 2018
Just one day from World Hypertension Day, the SIAComunidad ‘For the American Heart’ initiative has reached an impressive number of activities from... more
May Measurement Month (MMM) – an awareness-raising initiative building on World Hypertension Day
Posted on May 10, 2018
Following the success of the inaugural May Measurement Month (MMM) in 2017, programmes are already in place to repeat the mass synchronized... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Koji Hasegawa
President
Affiliations/Memberships Director, Division of Translational Research, Kyoto Medical Center Leader, Cardiovascular Clinical Research Network, National Hospital Organization Visiting Professor, University of Shizuoka (more…) more
-
Augusto Gallino
President Elect
Affiliations/Memberships University of Zurich Zurich Switzerland Research interests Atherosclerosis ACS CV Imaging Antithrombotic TX Transplantation President Elect, International Society of Cardiovascular Pharmacotherapy more
-
Thomas Kahan
Treasurer
Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine Karolinska Institutet Senior Consultant in Cardiology Department of (more…) more
-
Dennis Cokkinos
Secretary
Affiliations/Memberships Professor of Cardiology Emeritus, University of Athens Honorary Director of Onassis Cardiac Surgery Center Head of Cardiovascular Research Division, Biomedical Research Foundation Academy of Athens more
-
Felipe Martínez
ISCP Executive Committee
Affiliations/Memberships Emeritus Professor of Medicine Cordoba National University Director Instituto DAMIC-Fundación Rusculleda Córdoba Argentina Fellow of the European Society of Cardiology (FESC) (more…) more
-
Gheorghe-Andrei Dan
ISCP Executive Committee
Affiliations Professor of Cardiology and Internal Medicine Head of Internal Medicine Clinic Head of Cardiology Department Senior Researcher 1st dgr Colentina University Hospital Medicine Faculty Carol Davila (more…) more
-
Antoni Martínez-Rubio
ISCP Executive Committee
Affiliations/Memberships Department of Cardiology University Hospital Sabadell Autonomous University of Barcelona Barcelona Spain International Society of Cardiovascular Pharmacotherapy Research interests (more…) more
-
Juan Carlos Kaski
ISCP Executive Committee
Affiliations/Memberships Professor of Cardiovascular Science St George's University of London London UK Research interests Coronary artery disease Microvascular angina Cardiac biomarkers Coronary artery spasm Inflammation more
Featured Review
Cardiovascular Management of Adults with Marfan Syndrome
Yukiko Isekame, Sabiha Gati, Jose Antonio Aragon-Martin, Rachel Bastiaenen, Sreenivasa Rao Kondapally Seshasai, Anne Child
Marfan syndrome (MFS) is a disease in which connective tissue becomes weak secondary to fibrillin-1 mutations, resulting in aortic dilatation, aneurysm formation, aortic dissection, aortic regurgitation and mitral valve prolapse (MVP; see Table 1). Epidemiology MFS is an autosomal dominant condition: 75 % of all patients inherit the condition from...
